Literature DB >> 8565751

Impact of international autoimmune hepatitis group scoring system in definition of autoimmune hepatitis. An Italian experience.

F B Bianchi1, F Cassani, M Lenzi, G Ballardini, L Muratori, F Giostra, D Zauli.   

Abstract

We have reclassified 110 patients with autoantibody-positive cryptogenic chronic hepatitis according tot he aggregate scoring system proposed by the International Autoimmune Hepatitis Group for signs of hepatitis C virus (HCV) infection and the newly proposed terminology of "unclassified" chronic hepatitis. Anti-HCV and HCV viremia were assessed by second-generation assays and reverse transcription-polymerase chain reaction. Immunomorphological and immunochemical characterizations of antinuclear, smooth, muscle, liver-kidney microsomal type 1, and liver cytosol type 1 autoantibodies were also performed. All 45 anti-HCV negative patients fulfilled the score criteria for the diagnosis of "definite" or "probable" autoimmune hepatitis (AIH). Eight anti-HCV-positive cases reached the score of "probable" AIH, whereas the remaining 57 cases were diagnosed as unclassified chronic hepatitis. The scoring system allows the correct identification of all autoimmune cases without HCV infection. Autoimmune hepatitis runs a more severe disease course than unclassified chronic hepatitis, whose clinical and histological features are similar to those of autoantibody-negative chronic hepatitis C.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8565751     DOI: 10.1007/bf02208600

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  20 in total

1.  Hepatitis C virus and autoimmunity: fortuitous association or reality?

Authors:  F Lunel
Journal:  Gastroenterology       Date:  1994-11       Impact factor: 22.682

2.  Anti-actin antibodies: a new test for an old problem.

Authors:  M Fusconi; F Cassani; D Zauli; M Lenzi; G Ballardini; U Volta; F B Bianchi
Journal:  J Immunol Methods       Date:  1990-06-12       Impact factor: 2.303

3.  Meeting report: International Autoimmune Hepatitis Group.

Authors:  P J Johnson; I G McFarlane
Journal:  Hepatology       Date:  1993-10       Impact factor: 17.425

4.  Acute exacerbation of liver disease during interferon alfa therapy for chronic hepatitis C.

Authors:  M Shindo; A M Di Bisceglie; J H Hoofnagle
Journal:  Gastroenterology       Date:  1992-04       Impact factor: 22.682

5.  Antibodies to hepatitis C virus in autoimmune liver disease: evidence for geographical heterogeneity.

Authors:  M Lenzi; P J Johnson; I G McFarlane; G Ballardini; H M Smith; B M McFarlane; C Bridger; D Vergani; F B Bianchi; R Williams
Journal:  Lancet       Date:  1991-08-03       Impact factor: 79.321

6.  Immunomorphological characterisation of antinuclear antibodies in chronic liver disease.

Authors:  F Cassani; F B Bianchi; M Lenzi; U Volta; E Pisi
Journal:  J Clin Pathol       Date:  1985-07       Impact factor: 3.411

7.  Heterogeneity of liver/kidney microsomal antibody type 1 in autoimmune hepatitis and hepatitis C virus related liver disease.

Authors:  L Muratori; M Lenzi; Y Ma; M Cataleta; G Mieli-Vergani; D Vergani; F B Bianchi
Journal:  Gut       Date:  1995-09       Impact factor: 23.059

8.  Serum autoantibodies and the diagnosis of type-1 autoimmune hepatitis in Italy: a reappraisal at the light of hepatitis C virus infection.

Authors:  F Cassani; L Muratori; P Manotti; M Lenzi; M Fusconi; G Ballardini; L Selleri; U Volta; D Zauli; R Miniero
Journal:  Gut       Date:  1992-09       Impact factor: 23.059

9.  Anti-GOR and hepatitis C virus in autoimmune liver diseases.

Authors:  G Michel; A Ritter; G Gerken; K H Meyer zum Büschenfelde; R Decker; M P Manns
Journal:  Lancet       Date:  1992-02-01       Impact factor: 79.321

10.  HCV-marker-positive autoimmune-type chronic active hepatitis: a possible relation between HCV infection and liver autoreaction.

Authors:  M Zeniya; Y Aizawa; F Watanabe; T Kawabe; M Hara; M Sakaguchi; G Toda
Journal:  Liver       Date:  1994-08
View more
  1 in total

1.  A new approach for treatment of hepatitis C in hepatitis C-autoimmune hepatitis overlap syndrome.

Authors:  Rabin Rahmani; Thomas D Schiano
Journal:  Gastroenterol Hepatol (N Y)       Date:  2010-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.